BREA, Calif. (September 30, 2024) – Beckman Coulter,
Inc. continues its tradition of displaying current and upcoming
laboratory solutions at the World Stem Cell Summit, which is being
held at the Marriott Renaissance Center in Detroit, Mich., October
4-6. Visitors to Booth 24 will see the latest in analyzers
and services designed to optimize productivity and workflow
efficiency.
Broad cellular analysis and regenerative medicine portfolios will
allow Beckman Coulter to feature more ways to streamline lab
performance than ever, with an emphasis on complete laboratory
solutions. Featured new and upcoming products will
include:
- The Quantum Cell Expansion System, a closed, automated system
for cell expansion.
- The GenomeLab GeXP Genetic Analysis System.
- The Multisizer 4 particle sizing and counting system.
- Kaluza software for multiparametric analysis in flow
cytometry.
- The Gallios multi-color flow cytometer displaying Kaluza
software v1.1.
- The CompuCyte iCys Research Imaging System with iGeneration
software.
"Beckman Coulter's experience and current product portfolio are
focused on solutions that help to standardize and optimize
bioprocess methods and applications in order to reduce time,
improve quality and enhance the overall performance of the
laboratory," said Brad Calvin, vice president and general manager
of the Beckman Coulter Flow Cytometry Business Center. "Our
expanded portfolio offers complete and comprehensive solutions for
today's cellular therapy research workflows."
Three "Luncheon with the Experts" sessions hosted by Beckman
Coulter will provide attendees with the opportunity to learn how
they may benefit from the analytical and workflow capabilities of
the new systems:
Defining Pluripotency with Multiplex Gene Expression will
focus on the utilization of gene expression profiles to effectively
characterize and define fully reprogrammed human iPSCs derived from
somatic cells.
Optimizing, Automating and Standardizing Cell Therapy Research
Workflows offers attendees strategies for standardization and
enhanced optimization of bioprocessing and analysis
techniques.
Characterizing Embryoid Bodies with the Coulter Principle
will cover key features of the Coulter Principle and best practices
for its use with stem cells, along with a brief review of recent
publications implementing the Coulter Principle for characterizing
embryoid bodies.
As a proud sponsor of the 2010 World Stem Cell Summit, Beckman
Coulter is offering $100 discount registration passes to our
partners and customers who are attending the event. For complete
details on all of Beckman Coulter's products, workshops, posters
and activities at this year's event, visit www.coulterflow.com/worldstemcellreport.html
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. This year marks the
company's 75th anniversary of advancing healthcare. More than
200,000 Beckman Coulter systems operate in laboratories around the
world, supplying critical information for improving patient health
and reducing the cost of care. Recurring revenue, consisting of
consumable supplies (including reagent test kits), service and
operating-type lease payments, represents about 80 percent of the
company's 2009 revenue of $3.3 billion. For more information, visit
www.beckmancoulter.com or
www.beckmancoulter.com/75years.
Beckman Coulter and the stylized logo are registered trademarks
of Beckman Coulter, Inc.
Gallios, Kaluza, GenomeLab and Multisizer are trademarks of Beckman
Coulter, Inc.
SOURCE